María Maqueda - Researcher Profile | RDL Research Database

Publications

2 shown

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

Jong‐Mu Sun , Lin Shen , Manish A. Shah +22 more

Merck Sharp & Dohme.

2021 The Lancet 1394 citations

ColoStem, a core oncofetal signature that identifies poor prognosis colorectal tumors

Laura Solé , Eric Cantón , María Maqueda +15 more

Our results reveal ColoStem and EpiColoStem tests as valuable tools for refining patient prognosis through the identification of fetal-type CRC tumors.

2025 British Journal of Cancer 0 citations

Frequent Co-Authors

Researcher Info

h-index: 1
Publications: 2
Citations: 1,394
Institution: Vall d'Hebron Institute of Oncology

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-9304-1714

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.